関連する実験動画
Updated: May 6, 2026

08:12
Intramyocardial Cell Delivery: Observations in Murine Hearts
Published on: January 24, 2014
13.7K
短期間性細胞循環誘導 低急性心不全の治療
Riham R E Abouleisa1, Abou Bakr M Salama1,2, Qinghui Ou1
1From the Institute of Molecular Cardiology (R.R.E.A., A.B.M.S., Q.O., X.-L.T., M.S., Y.G., Y.N., K.M.K., S.K.H., R.B., T.M.A.M.), University of Louisville, KY.
Circulation
|January 21, 2022
まとめ
この研究では,4つの細胞サイクル因子 (4F) を使用して,強制的な心筋細胞増殖のための重要な再プログラム段階を特定しました. ネズミと豚のモデルでの臨床前試験では,心筋梗塞後の心機能と安全性が改善され,心不全に対する4F遺伝子治療が進んだ.
科学分野:
- 心血管生物学
- 再生医療
- 遺伝子療法
背景:
- 心筋梗塞 (MI) の後の内生性心臓再生が限られている.
- 前回の研究では,4つの細胞サイクル因子 (4F) が心筋細胞の増殖を促進し,マウスの心臓機能を改善することが示されました.
- 4F治療のメカニズムと臨床前有効性を理解する必要があります.
研究 の 目的:
- 4F誘発の心筋細胞増殖の過程における再プログラム段階を特定する.
- 4F遺伝子療法の臨床前試験を大型動物モデルで実施する.
主な方法:
- テンポラル単細胞RNA配列解析で 心筋細胞の再プログラミングを分析する
- カーディオミオサイトに特異的な一時的なレンチウイルスベクター (TNNT2-4Fポリシストロニック- NIL) の発現.
- ネズミと豚のMIモデルにおけるウイルスベクターの心臓内注射
主要な成果:
- 4Fは心臓肌細胞の15%で細胞周期の再プログラムを引き起こし,代謝変化と関連しています.
- TNNT2-4Fポリシストロニック- NIL治療は,エジェクション分数を大幅に改善し,ラットと豚の傷痕サイズを減少させた.
- 治療後4ヶ月までのラットでは,持続的な心臓機能の改善と不律または腫瘍発生の欠如が観察されました.
結論:
- 強制的な心筋細胞増殖に関するメカニズム的な洞察が得られた.
- 癌的リスクを最小限に抑える新しい一時的および心筋細胞特有のウイルス構造.
- この研究は,心不全の治療における4F遺伝子療法の臨床的実現可能性を裏付けています.
関連する概念動画
The Cardiac Cycle
77.6K
The heart beats rhythmically in a sequence called the cardiac cycle—a rapid coordination of contraction (systole) and relaxation (diastole).
The Process
Electrical signals—sent from the sinoatrial (SA) node in the right atrial wall to the atrioventricular (AV) node between the right atrium and right ventricle—cause both atria to simultaneously contract. When the signal reaches the AV node, it pauses for approximately a tenth of a second, allowing the atria to contract and...
The Process
Electrical signals—sent from the sinoatrial (SA) node in the right atrial wall to the atrioventricular (AV) node between the right atrium and right ventricle—cause both atria to simultaneously contract. When the signal reaches the AV node, it pauses for approximately a tenth of a second, allowing the atria to contract and...
77.6K
Electrophysiology of Normal Cardiac Rhythm
7.8K
The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase...
7.8K
Imbalances in Cardiac Output
3.3K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.3K
Heart Failure II: Pathophysiology
2.1K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
2.1K
Cardiomyopathy II: Dilated Cardiomyopathy
798
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
798
Cardiomyopathy V: Interprofessional Care
761
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
761

